| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
HIV Infections | 43 | 1991 | 137 |
Why?
|
Acquired Immunodeficiency Syndrome | 22 | 1984 | 85 |
Why?
|
Anti-HIV Agents | 9 | 1999 | 44 |
Why?
|
Anti-Retroviral Agents | 4 | 2004 | 13 |
Why?
|
Practice Guidelines as Topic | 10 | 1993 | 174 |
Why?
|
Antiretroviral Therapy, Highly Active | 6 | 2000 | 27 |
Why?
|
Managed Care Programs | 7 | 1999 | 50 |
Why?
|
Hepatitis C | 4 | 2005 | 18 |
Why?
|
Quality of Health Care | 5 | 2000 | 85 |
Why?
|
Health Personnel | 4 | 1991 | 54 |
Why?
|
United States | 28 | 1984 | 604 |
Why?
|
Infection Control | 5 | 1993 | 20 |
Why?
|
Humans | 72 | 1980 | 1858 |
Why?
|
Outcome Assessment (Health Care) | 4 | 2000 | 164 |
Why?
|
HIV | 4 | 1995 | 32 |
Why?
|
Quality Assurance, Health Care | 4 | 1999 | 83 |
Why?
|
Antiviral Agents | 5 | 2004 | 91 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 1998 | 41 |
Why?
|
Patient Compliance | 8 | 2000 | 114 |
Why?
|
Health Care Costs | 4 | 2000 | 73 |
Why?
|
AIDS Serodiagnosis | 4 | 1993 | 10 |
Why?
|
Patient Acceptance of Health Care | 2 | 2005 | 70 |
Why?
|
Centers for Disease Control and Prevention (U.S.) | 7 | 1984 | 20 |
Why?
|
Cross Infection | 7 | 1980 | 46 |
Why?
|
Hepatitis B | 5 | 1986 | 18 |
Why?
|
Disaster Planning | 2 | 2001 | 7 |
Why?
|
Clinical Competence | 2 | 2003 | 130 |
Why?
|
Cost of Illness | 2 | 2002 | 54 |
Why?
|
Primary Health Care | 2 | 2008 | 151 |
Why?
|
Treatment Outcome | 8 | 1998 | 662 |
Why?
|
Cost Control | 2 | 2002 | 26 |
Why?
|
Ambulatory Care | 2 | 2003 | 106 |
Why?
|
Health Services Accessibility | 2 | 2001 | 72 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2009 | 4 |
Why?
|
Anus Diseases | 1 | 2008 | 7 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2008 | 10 |
Why?
|
Erectile Dysfunction | 1 | 2008 | 11 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2008 | 17 |
Why?
|
Methicillin | 1 | 2008 | 5 |
Why?
|
Demography | 1 | 2008 | 87 |
Why?
|
General Surgery | 1 | 2009 | 34 |
Why?
|
Medical Assistance | 2 | 2004 | 7 |
Why?
|
Papillomavirus Infections | 1 | 2008 | 39 |
Why?
|
Personal Health Services | 1 | 2007 | 8 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2007 | 1 |
Why?
|
Drug Costs | 2 | 2004 | 22 |
Why?
|
Receptors, CCR5 | 1 | 2007 | 10 |
Why?
|
Education, Medical, Continuing | 1 | 2008 | 54 |
Why?
|
Staphylococcal Infections | 1 | 2008 | 63 |
Why?
|
Cyclohexanes | 1 | 2007 | 15 |
Why?
|
Models, Economic | 1 | 2007 | 14 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 125 |
Why?
|
Medical Records Systems, Computerized | 1 | 2007 | 25 |
Why?
|
Physicians | 1 | 2009 | 104 |
Why?
|
Total Quality Management | 2 | 2003 | 31 |
Why?
|
Personnel, Hospital | 5 | 1982 | 17 |
Why?
|
Physician's Practice Patterns | 2 | 2002 | 149 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 48 |
Why?
|
Triazoles | 1 | 2007 | 31 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 25 |
Why?
|
Patient Education as Topic | 2 | 1995 | 128 |
Why?
|
Universal Precautions | 3 | 1993 | 3 |
Why?
|
Metabolic Syndrome X | 1 | 2007 | 34 |
Why?
|
Nurse's Role | 1 | 2006 | 13 |
Why?
|
Physician Assistants | 1 | 2006 | 10 |
Why?
|
HIV-1 | 3 | 2002 | 93 |
Why?
|
Diagnostic Tests, Routine | 1 | 2006 | 34 |
Why?
|
Insurance Benefits | 1 | 2006 | 3 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 145 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2006 | 3 |
Why?
|
Nurse Practitioners | 1 | 2006 | 27 |
Why?
|
Research | 1 | 2007 | 125 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 165 |
Why?
|
Health Policy | 1 | 2006 | 52 |
Why?
|
Ambulatory Care Facilities | 1 | 2005 | 27 |
Why?
|
Delivery of Health Care | 2 | 2000 | 102 |
Why?
|
Risk Management | 2 | 1999 | 15 |
Why?
|
Disease Management | 2 | 2001 | 23 |
Why?
|
Medicare | 1 | 2006 | 48 |
Why?
|
Home Care Services | 2 | 1994 | 34 |
Why?
|
Viral Load | 4 | 2001 | 53 |
Why?
|
Appointments and Schedules | 1 | 2004 | 27 |
Why?
|
Occupational Diseases | 4 | 1986 | 51 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2004 | 21 |
Why?
|
Health Surveys | 1 | 2005 | 104 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 195 |
Why?
|
Guideline Adherence | 1 | 2004 | 64 |
Why?
|
Health Manpower | 3 | 1986 | 6 |
Why?
|
Patient-Centered Care | 1 | 2004 | 30 |
Why?
|
Prescription Fees | 1 | 2002 | 5 |
Why?
|
Statistics as Topic | 1 | 2003 | 133 |
Why?
|
Pharmacy Service, Hospital | 1 | 2002 | 9 |
Why?
|
Medicine | 1 | 2002 | 26 |
Why?
|
Specialization | 1 | 2002 | 31 |
Why?
|
Myocardial Infarction | 1 | 2007 | 129 |
Why?
|
Adolescent | 6 | 2003 | 892 |
Why?
|
HIV Seropositivity | 2 | 1995 | 24 |
Why?
|
Terrorism | 1 | 2001 | 9 |
Why?
|
Consumer Participation | 1 | 2001 | 16 |
Why?
|
Adult | 10 | 1994 | 1321 |
Why?
|
Pregnancy Complications, Infectious | 3 | 1986 | 35 |
Why?
|
Medical Errors | 1 | 2000 | 22 |
Why?
|
Risk Factors | 7 | 1993 | 557 |
Why?
|
Clinical Trials as Topic | 3 | 2007 | 251 |
Why?
|
Equipment and Supplies, Hospital | 2 | 1980 | 4 |
Why?
|
Female | 12 | 1986 | 1646 |
Why?
|
Equipment Contamination | 1 | 1997 | 15 |
Why?
|
Male | 10 | 1994 | 1558 |
Why?
|
Infection Control Practitioners | 2 | 1991 | 1 |
Why?
|
Incidence | 3 | 1992 | 337 |
Why?
|
Cost-Benefit Analysis | 3 | 1980 | 118 |
Why?
|
Catheters, Indwelling | 1 | 1994 | 46 |
Why?
|
Caregivers | 1 | 1995 | 50 |
Why?
|
Organizational Case Studies | 2 | 2003 | 13 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 1993 | 3 |
Why?
|
Occupational Health Services | 2 | 1982 | 11 |
Why?
|
Confidentiality | 2 | 2001 | 14 |
Why?
|
Occupational Medicine | 2 | 1982 | 16 |
Why?
|
Cooperative Behavior | 1 | 1994 | 70 |
Why?
|
Middle Aged | 6 | 1994 | 1166 |
Why?
|
Disease Outbreaks | 1 | 1993 | 61 |
Why?
|
Institute of Medicine (U.S.) | 2 | 2000 | 6 |
Why?
|
Hepatitis B e Antigens | 1 | 1991 | 3 |
Why?
|
Occupational Exposure | 1 | 1993 | 53 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1992 | 21 |
Why?
|
Truth Disclosure | 1 | 1991 | 21 |
Why?
|
Patients | 1 | 1991 | 37 |
Why?
|
Drug Resistance, Microbial | 2 | 2000 | 53 |
Why?
|
Drug Therapy, Combination | 2 | 2004 | 189 |
Why?
|
Laboratory Infection | 2 | 1986 | 2 |
Why?
|
Problem Solving | 3 | 1993 | 39 |
Why?
|
Patient Satisfaction | 2 | 2000 | 120 |
Why?
|
Pregnancy | 4 | 1986 | 457 |
Why?
|
Health Occupations | 1 | 1988 | 2 |
Why?
|
United States Occupational Safety and Health Administration | 1 | 1988 | 3 |
Why?
|
Homosexuality, Male | 1 | 2008 | 13 |
Why?
|
Condoms | 1 | 2008 | 9 |
Why?
|
Methicillin Resistance | 1 | 2008 | 9 |
Why?
|
Australia | 1 | 2008 | 27 |
Why?
|
Genome, Human | 1 | 2007 | 29 |
Why?
|
Weight Gain | 1 | 2007 | 30 |
Why?
|
Congresses as Topic | 1 | 2007 | 30 |
Why?
|
Life Expectancy | 1 | 2007 | 20 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 55 |
Why?
|
Economics, Pharmaceutical | 1 | 2006 | 7 |
Why?
|
Drug Resistance, Viral | 1 | 2007 | 17 |
Why?
|
Drug Administration Schedule | 2 | 1998 | 193 |
Why?
|
Legislation, Drug | 1 | 2006 | 6 |
Why?
|
Health Benefit Plans, Employee | 1 | 2006 | 7 |
Why?
|
RNA, Viral | 1 | 2008 | 91 |
Why?
|
Informed Consent | 1 | 2006 | 62 |
Why?
|
Health Care Rationing | 1 | 2005 | 7 |
Why?
|
Insurance Coverage | 1 | 2006 | 26 |
Why?
|
Drug Prescriptions | 1 | 2006 | 35 |
Why?
|
Virus Diseases | 1 | 1986 | 50 |
Why?
|
Mandatory Testing | 1 | 2005 | 1 |
Why?
|
Rate Setting and Review | 1 | 2004 | 3 |
Why?
|
Hepatitis C, Chronic | 1 | 2004 | 10 |
Why?
|
Drug Industry | 1 | 2004 | 18 |
Why?
|
Drug Approval | 1 | 2004 | 15 |
Why?
|
Liver Failure | 1 | 2004 | 18 |
Why?
|
Sex Distribution | 1 | 2005 | 101 |
Why?
|
Polyethylene Glycols | 1 | 2004 | 45 |
Why?
|
Ribavirin | 1 | 2004 | 23 |
Why?
|
Liver Cirrhosis | 1 | 2004 | 48 |
Why?
|
Drug Combinations | 1 | 2004 | 96 |
Why?
|
Age Distribution | 1 | 2005 | 127 |
Why?
|
World Health | 1 | 2004 | 41 |
Why?
|
Health Plan Implementation | 1 | 2004 | 20 |
Why?
|
New York City | 1 | 2004 | 32 |
Why?
|
Needs Assessment | 1 | 2005 | 67 |
Why?
|
Medicaid | 1 | 2004 | 48 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2003 | 16 |
Why?
|
Drug Monitoring | 1 | 2004 | 33 |
Why?
|
Financing, Organized | 1 | 2003 | 8 |
Why?
|
Interferon-alpha | 1 | 2004 | 43 |
Why?
|
Benchmarking | 1 | 2004 | 28 |
Why?
|
Data Collection | 2 | 1986 | 137 |
Why?
|
Patient Rights | 1 | 2003 | 4 |
Why?
|
Comorbidity | 1 | 2005 | 191 |
Why?
|
Quality Indicators, Health Care | 1 | 2003 | 34 |
Why?
|
Haiti | 1 | 2002 | 4 |
Why?
|
Africa South of the Sahara | 1 | 2002 | 9 |
Why?
|
Brazil | 1 | 2002 | 14 |
Why?
|
Communicable Disease Control | 1 | 1982 | 20 |
Why?
|
Developing Countries | 1 | 2002 | 28 |
Why?
|
Bioterrorism | 1 | 2001 | 6 |
Why?
|
Privacy | 1 | 2001 | 3 |
Why?
|
Decision Making | 1 | 2004 | 130 |
Why?
|
CD4 Lymphocyte Count | 1 | 2002 | 50 |
Why?
|
Patient Advocacy | 1 | 2001 | 35 |
Why?
|
Disposable Equipment | 1 | 1981 | 7 |
Why?
|
Prognosis | 1 | 2005 | 389 |
Why?
|
Thermometers | 1 | 1981 | 5 |
Why?
|
Professional Staff Committees | 1 | 1980 | 6 |
Why?
|
Provider-Sponsored Organizations | 1 | 2000 | 1 |
Why?
|
Severity of Illness Index | 2 | 1998 | 359 |
Why?
|
Risk Assessment | 1 | 2005 | 325 |
Why?
|
Genotype | 1 | 2002 | 175 |
Why?
|
Costs and Cost Analysis | 1 | 1999 | 71 |
Why?
|
New York | 3 | 1980 | 425 |
Why?
|
Phenotype | 1 | 2002 | 304 |
Why?
|
Cohort Studies | 1 | 2002 | 333 |
Why?
|
Guidelines as Topic | 1 | 1999 | 77 |
Why?
|
Time Factors | 2 | 1998 | 896 |
Why?
|
Itraconazole | 1 | 1998 | 5 |
Why?
|
Candidiasis, Oral | 1 | 1998 | 12 |
Why?
|
Blood-Borne Pathogens | 1 | 1997 | 2 |
Why?
|
Child | 1 | 2007 | 750 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 1997 | 10 |
Why?
|
Hospitalization | 1 | 2001 | 169 |
Why?
|
Equipment Safety | 1 | 1997 | 25 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 178 |
Why?
|
Antifungal Agents | 1 | 1998 | 34 |
Why?
|
Cytomegalovirus Infections | 2 | 1986 | 39 |
Why?
|
Deltaretrovirus | 2 | 1986 | 2 |
Why?
|
Algorithms | 1 | 1999 | 226 |
Why?
|
Mass Screening | 2 | 1982 | 126 |
Why?
|
Risk | 2 | 1986 | 203 |
Why?
|
Counseling | 1 | 1995 | 50 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 1994 | 10 |
Why?
|
Catheterization, Central Venous | 1 | 1994 | 46 |
Why?
|
Environmental Microbiology | 1 | 1993 | 4 |
Why?
|
Health Facilities | 1 | 1993 | 8 |
Why?
|
Health Priorities | 1 | 1993 | 11 |
Why?
|
Vision Disorders | 1 | 1994 | 44 |
Why?
|
Tuberculin Test | 1 | 1992 | 12 |
Why?
|
Societies | 1 | 1991 | 8 |
Why?
|
Vaccination | 1 | 1993 | 92 |
Why?
|
Animals | 1 | 2007 | 1032 |
Why?
|
Hospital Departments | 1 | 1988 | 15 |
Why?
|
Viral Hepatitis Vaccines | 1 | 1986 | 2 |
Why?
|
Disinfectants | 1 | 1986 | 10 |
Why?
|
HIV Antibodies | 1 | 1986 | 16 |
Why?
|
Hepatitis B Vaccines | 1 | 1986 | 17 |
Why?
|
Retroviridae Infections | 1 | 1986 | 7 |
Why?
|
Rubella | 1 | 1986 | 5 |
Why?
|
Rubella Vaccine | 1 | 1986 | 9 |
Why?
|
Mass Media | 1 | 1986 | 15 |
Why?
|
Measles | 1 | 1986 | 13 |
Why?
|
Measles Vaccine | 1 | 1986 | 9 |
Why?
|
Chickenpox | 1 | 1986 | 20 |
Why?
|
Herpes Simplex | 1 | 1986 | 31 |
Why?
|
Vaccines | 1 | 1986 | 33 |
Why?
|
Tuberculosis | 1 | 1984 | 24 |
Why?
|
Antibodies, Viral | 1 | 1986 | 104 |
Why?
|
Hospitals, University | 1 | 1982 | 59 |
Why?
|
Recombinant Proteins | 1 | 2004 | 290 |
Why?
|
Plastics | 1 | 1981 | 11 |
Why?
|
Infant, Newborn | 1 | 1986 | 389 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1980 | 17 |
Why?
|
Pharyngeal Diseases | 1 | 1998 | 5 |
Why?
|
Solutions | 1 | 1998 | 54 |
Why?
|
Disease-Free Survival | 1 | 1998 | 102 |
Why?
|
Administration, Oral | 1 | 1998 | 170 |
Why?
|
Biopsy | 1 | 1994 | 208 |
Why?
|
Magnetic Resonance Imaging | 1 | 1994 | 295 |
Why?
|
Brain | 1 | 1994 | 305 |
Why?
|
Aged | 1 | 1998 | 992 |
Why?
|
